Netex participates in the 9th Meeting of MAB Companies

Organised by Bolsas y Mercados Españoles (BME), the MAB Meeting takes place within the Medcap Forum, which invites “small and mid caps” listed on the Spanish stock exchange and investors interested in them to meet at the Madrid Stock Exchange (Plaza de la Lealtad, nº1), May 29th and 30th.

During the Meeting, discussion panels will be held to discuss issues related to the Alternative Stock Market, and managers of companies quoted in this market will have the opportunity to present their company to investors, either through private “one-to-one” meetings or through “Discovery Meetings”, all activities encompassed in a networking environment among companies, investors, analysts and other personalities in the financial field.

Netex will attend requests for private “one-to-one” meetings with institutional, national and foreign investors and to present the company to groups of investors through “Discovery Meetings”. The “one-to-one” meetings will take place during the May 30th preferably and, if necessary, on the afternoon of the 29th. As for the “Discovery Meetings”, they will be held during May 29th and 30th, depending on availability.

MedCap 2018 – Interview with Carlos Ezquerro, CEO of Netex

The Medcap Forum has established itself as a reference event in Spain and Europe, due to the dimension it has reached since its creation, more than a decade ago, and for the versatility of its format More than 100 listed companies, 150 investors and 800 attendees are present at the event, which results in more than 1,200 private meetings between listed companies and buy-side investors.

It is a key event every year for European investors and small and medium capitalisation companies listed in Spain whose main objective is to promote the liquidity and financing capacity of medium and small cap companies listed on the Stock Exchange. The Medcap Forum is also a platform for the exchange of ideas and reflection on topics relevant to the financial and academic community.

To schedule a conversation, please email us at